Screening for Gestational Diabetes: Summary of the Evidence (continued)

You Are Here: AHRQ Home > Clinical Information > U.S. Preventive Services Task Force (USPSTF) > Guide to Clinical Preventive Services, 2001-2004 > Screening: Gestational Diabetes Mellitus > Summary of the Evidence

References

1. Magee MS, Walden CE, Benedetti TJ, Knopp RH. Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. JAMA 1993;269:609-15.

2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 30, September 2001. Obstet Gynecol 2001;98:525-38.

3. Solomon CG , Willet WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078-83.

4. Marquette GP, Klein VR, Niebyl JR. Efficacy of screening for gestational diabetes. Am J Perinatol 1985;2:7-9.

5. Moses RG, Moses J, Davis WS. Gestational diabetes: do lean young Caucasian women need to be tested? Diabetes Care 1998;21:1803-6.

6. Hunter DJS. Diabetes in pregnancy. In: Iain Chalmers, Murray Enkin, Marc J.N.C. Keirse, eds. Effective Care in Pregnancy and Childbirth. Toronto: Oxford University Press; 1989:578-93.

7. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus: management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Austral 1998;169:93-7.

8. Oats JJ. Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Overview and commentary on first session. Diabetes Care 1998;21:B58-9.

9. U.S. Preventive Services Task Force. Screening for diabetes mellitus. In: Guide to Clinical Preventive Services, 2nd. ed. Washington, DC: Office of Disease Prevention and Health Promotion, U.S. Government Printing Office; 1996:193-208.

10. American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care 2002;25 (suppl 1):S94-6.

11. Canadian Task Force on the Periodic Health Examination. Screening for gestational diabetes mellitus. Can Med Assoc J 1992;147:435-43.

12. Wilkins-Haug L, Horton JA, Cruess DF, Frigoletto FD. Antepartum screening in the office-based practice: findings from the collaborative ambulatory research network. Obstet Gynecol 1996;88:483-9.

13. American College of Obstetricians and Gynecologists. Diabetes and Pregnancy. Washington, DC. American College of Obstetricians and Gynecologists. Technical Bulletin No. 200 1994.

14. Harris RP, Helfand M, Woolf SH, et al. Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001;2 (suppl 3):21-35.

15. Brody S, Harris RP, Krasnov C, Lohr KN, Sutton S, Whitener L. Screening for Gestational Diabetes. Systematic Evidence Review. Rockville, MD: Agency for Healthcare Research and Quality.

16. Sacks DA, Greenspoon JS, Abu-Fadil S, Henry HM, Wolde-Tsadik G , Yao JFF. Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. Am J Obstet Gynecol 1995;172:607-14.

17. Sermer M, Naylor DC, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995;173:146-56.

18. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus—how tight is tight enough: small for gestational age vs. large for gestational age? Am J Obstet Gynecol 1989;161:646-53.

19. Naylor CD. Diagnosing gestational diabetes: is the gold standard valid? Diabetes Care 1989;12:565-72.

20. Garner P, Okun N, Keely E, et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol 1997;177:190-5.

21. O'Sullivan JB, Gellis SS, Dandrow RV, Tenney BO. The potential diabetic and her treatment in pregnancy. Obstet Gynecol 1966;27:683-9.

22. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Tri-Hospital Gestational Diabetes Investigators. JAMA 1996;275:1165-70.

23. Lu G, Rouse D, Dubard M, Cliver S. The impact of lower threshold values for the detection of gestational diabetes mellitus. Obstet Gynecol 2000;95:S44.

24. Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust NZ J Obstet Gynaecol 1996;36:239-47.

25. Pettitt DJ, Knowler WC, Baird HR, Bennett PH. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in Pima Indians. Diabetes Care 1980;3:458-64.

26. Adams KM, Li H, Nelson RL, Ogburn PL Jr, Danilenko-Dixon DR. Sequelae of unrecognized gestational diabetes. Am J Obstet Gynecol 1998;178:1321-32.

27. Li DFH, Wong VCW, O'Hoy KMKY, Ma HK. Is treatment needed for mild impairment of glucose in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987;94:851-4.

28. Gross TL, Sokol RJ, Williams T, Thompson K. Shoulder dystocia: a fetal-physician risk. Am J Obstet Gynecol 1987;156:1408-18.

29. Kjos SL, Schaefer-Graf U, Sardesi S, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001;24:1904-10.

30. Lipscomb KR, Gregory K, Shaw K. The outcome of macrosomic infants weighing at least 4500 grams: Los Angeles County + University of Southern California experience. Obstet Gynecol 1995;85:558-64.

31. Berard J, Dufour P, Vinatier D, et al. Fetal macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases >4500 g. Eur J Obstet Gynecol Reprod Biol 1998;77:51-9.

32. Morrison JC, Sanders JR, Magann EF, Wiser WL. The diagnosis and management of dystocia of the shoulder. Surg Gynecol Obstet 1992;175:515-22.

33. Hardy AE. Birth injuries of the brachial plexus: incidence and prognosis. J Bone Joint Surg Br 1981;63-B:98-101.

34. Ventura SJ, Martin JA, Curtin SC, Mathews TJ, Park MM. Births: final data for 1998. Natl Vital Stat Rep 2000;48:1-100.

35. Perlow JH, Wigton T, Hart J, Strassner HT, Nageotte MP, Wolk BM. Birth trauma. A five-year review of incidence and associated perinatal factors. J Reprod Med 19 96;41:754-60.

36. Oppenheim WL, Davis A, Growdon WA, Dorey FJ, Davlin LB. Clavicle fractures in the newborn. Clin Orthop 1990;250:176-80.

37. Chez RA, Carlan S, Greenberg SL, Spellacy WN. Fractured clavicle is an unavoidable event. Am J Obstet Gynecol 1994;171:797-8.

38. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001;75:221-8.

39. Svare JA, Hansen BB, Molsted-Pedersen L. Perinatal complications in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2001;80:899-904.

40. Langer O. Management of gestational diabetes. Clin Obstet Gynecol 2000;43:106-15.

41. Langer O. Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus. Diabetes Care 1998;21(suppl 2):B91-8.

42. Langer O, Conway D, Berkus M, Xenakis E, Gonzales O. A comparison of glyburide and insulin on women with gestational diabetes mellitus. N Engl J Med 2000;343:1134-8.

43. Ogata E. Perinatal morbidity in offspring of diabetic mothers. Diabetes Rev 1995;3:652-7.

44. Hod M, Rabinerson D, Peled Y. Gestational diabetes mellitus: is it a clinical entity? Diabetes Reviews 1995;3:602-13.

45. Whitaker RC, Pepe MS, Seidel KD, Wright JA, Knopp RH. Gestational diabetes and the risk of offspring obesity. Pediatrics 1998;101:E9.

46. Beischer NA, Wein P, Sheedy MT, Werther GA, Gold H. Maternal glucose tolerance and obstetric complications in pregnancies in which the offspring developed type I diabetes. Diabetes Care 1994;17:832-4.

47. Vohr BR, McGarvey ST, Tucker R. Effects of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care 1999;22:1284-91.

48. Persson B, Gentz J, Moller E. followup of children of insulin dependent (type I) and gestational diabetic mothers. Growth pattern, glucose tolerance, insulin response, and HLA types. Acta Paediatr Scand 1984;73:778-84.

49. Lu GC, Rouse DJ, Dubard M, Cliver S, Kimberlin D, Hauth JC. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001;185:845-9.

50. Rouse DJ, Owen J. Prophylactic cesarean delivery for fetal macrosomia diagnosed by means of ultrasonography: A Faustian bargain? Am J Obstet Gynecol 1999;181:332-8.

51. Mondalou HD, Dorchester WL, Thorosian A, Freeman RK. Macrosomia: maternal, fetal, and neonatal implications. Obstet Gynecol 1980;55:420-4.

52. Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia: maternal characteristics and infant complications. Obstet Gynecol 1985;66:158-61.

53. Menticoglou SM, Manning FA, Morrison I, Harman CR. Must macrosomic fetuses be delivered by cesarean section? A review of outcome for 786 babies greater than or equal to 4,500 grams. Aust N Z J Obstet Gynaecol 1992;32:100-3.

54. Lazer S, Biale Y, Mazor M, Lewenthal H, Insler V. Complications associated with the macrosomic fetus. J Reprod Med 1986;31:501-5.

55. Jensen DM, Sorensen B, Feilberg-Jorgensen N, Westergaardt JG, Beck-Neilsen H. Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med 2000;17:281-6.

56. Schaffir JA, Lockwood CJ, Lapinski R, Yoon L, Alvarez M. Incidence of pregnancy-induced hypertension among gestational diabetics. Am J Perinatol 1995;12:252-4.

57. Suhonen L, Teramo K. Hypertension and pre-eclampsia in women with gestational glucose intolerance. Acta Obstetricia Et Gynecologica Scandinavica 1993;72:269-72.

58. Nachum Z, Ben-Shlomo I, Weiner E, Shalev E. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. BMJ 19 99;319:1223-7.

59. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333:1237-41.

60. Persson B, Strangenberg M, Hansson U, Norlander E. Gestational diabetes mellitus (GDM) comparative evaluation of two treatment regimens, diet versus insulin and diet. Diabetes 1985;11:101-5.

61. Naylor C.D., Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. Toronto Tri-Hospital Gestational Diabetes Project Investigators. New Engl J Med 1997;337:1591-6.

62. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991;40:131-5.

63. Harris R, Donahue K, Rathore S, Frame P, Woolf S, Lohr KN. Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality.

64. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Geneva: World Health Organization; 1999.

65. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.

66. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2002;25:S94-6.

67. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop- Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998;21(suppl 2):B161-7.

68. Deerochanawong C, Putiyanun C, Wongsuryrat M, Serirat S, Jinayon P. Comparison of National Diabetes Data Group and World Health Organization criteria for detecting gestational diabetes mellitus. Diabetologia 1996;39:1070-3.

69. Pettitt DJ, Bennett PH, Hanson RL, Narayan KMV, Knowler WC. Comparison of World Health Organization and National Diabetes Data Group procedures to detect abnormalities of glucose tolerance during pregnancy. Diabetes Care 1994;17:1264-8.

70. Coustan DR. Screening and testing for gestational diabetes mellitus. Obstet Gynecol Clin North Am 1996;23:125-36.

71. Moses RG, Griffiths RD. Can a diagnosis of gestational diabetes be an advantage to the outcome of pregnancy? J Society Gynecol Investi 1995;2:523-5.

72. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998;178:922-5.

73. Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564-8.

74. McDonald GW, Fisher GF, Burnham C. Reproducibility of the oral glucose tolerance test. Diabetes 19 65;14:473-80.

75. Troxler RG, Trabal JF, Malcolm CL. Interpretation of an abnormal glucose tolerance test encountered during multiphasic laboratory screening. Aviat Space Environ Med 19 75;46:729-35.

76. Olefsky JM, Reaven GM. Insulin and glucose responses to identical oral glucose tolerance tests performed forty-eight hours apart. Diabetes 1974;23:449-53.

77. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.

78. Sermer M, Naylor CD, Gare DJ, et al. Impact of time since last meal on the gestational glucose challenge test. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1994;171:607-16.

79. Landon MB, Gabbe ST, Sachs L. Management of diabetes mellitus and pregnancy: a survey of obstetricians and maternal-fetal specialists. Obstet Gynecol 1978;51:306-10.

80. Bancroft K, Tuffnell DJ, Mason GC, Rogerson LJ, Mansfield M. A randomised controlled pilot study of the management of gestational impaired glucose tolerance. Br J Obstet Gynecol 2000;107:959-63.

81. Li DF, Wong VC, O'Hoy KM, Yeung CY, Ma HK. Is treatment needed for mild impairment of glucose tolerance in pregnancy? A randomized controlled trial. Br J Obstet Gynaecol 1987;94:851-4.

82. Langer O, Anyaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 1989;161:593-9.

83. Buchanan TS, Kjos SL, Montoro MN, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994;17:275-83.

84. Walkinshaw S. Dietary regulation for 'gestational diabetes'. 2000. Cochrane Database of Systemic Reviews 2000;(2):CD000070.

85. Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol 19 94;170:1036-46; discussion 1046-7.

86. Drexel H, Bichler A, Sailer S, et al. Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus. Diabetes Care 1988;11:761-8.

87. Langer O, Brustman L, Anyaegbunam A, Mazze R. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 1987;157:758-63.

88. Shushan A, Ezra Y, Samueloff A. Early treatment of gestational diabetes reduces the rate of fetal macrosomia. Am J Perinatol 1997;14:253-6.

89. Kalkhoff RK. Therapeutic results of insulin therapy in gestational diabetes mellitus. Diabetes 19 85;34 Suppl 2:97-100.

90. Coustan DR, Imarah J. Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery, and birth trauma. Am J Obstet Gynecol 1984;150:836-42.

91. Gyves MT, Rodman HM, Little AB, Fanaroff AA, Merkatz IR. A modern approach to management of pregnant diabetics: a two-year analysis of perinatal outcomes. Am J Obstet Gynecol 19 77;128:606-16.

92. Landon MB, Gabbe SG. Antepartum fetal surveillance in gestational diabetes mellitus. Diabetes 19 85;34(suppl 2):50-4.

93. Girz BA, Divon MY, Merkatz IR. Sudden fetal death in women with well-controlled, intensively monitored gestational diabetes. J Perinatol 1992;12:229-33.

94. Kjos SL, Leung A, Henry OA. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 1995;173:1532-9.

95. Johnson JM, Lange IR, Harman CR, Torchia MG, Manning FA. Biophysical profile scoring in the management of the diabetic pregnancy. Obstet Gynecol 1988;72:841-6.

96. Rossi G, Somigliana E, Moschetta M, Bottani B, Barbieri M, Vignali M. Adequate timing fetal ultrasound to guide metabolic therapy in mild gestational diabetes mellitus. Acta Obstet Gynecol Scand 2000;79:649-54.

97. Kerbel D, Glazier R, Holzapfel S, Yeung M, Lofsky S. Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada. J Med Screen 1997;4:128-32.

98. Sjogren B, Robeus N, Hansson U. Gestational diabetes: a case-control study of women's experience of pregnancy, health and the child. J Psychosomatic Res 1994;38:815-22.

99. Langer N, Langer O. Emotional adjustment to diagnosis and intensified treatment of gestational diabetes. Obstet Gynecol 1994;84:329-34.

100. Spirito A, Williams C, Ruggiero L, Bond A, McGarvey ST, Coustan D. Psychological impact of the diagnosis of gestational diabetes. Obstet Gynecol 1989;73:562-6.

101. Feig DS, Chen E, Naylor CD. Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: A survey of cases and matched controls. Am J Obstet Gynecol 1998;178:386-93.

102. Knopp RH, Magee MS, Raisys V, Benedetti T, Bonet B. Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 1991;10:649-67.

103. Kolderup LB, Laros RK Jr, Musci TJ. Incidence of persistent birth injury in macrosomic infants: association with mode of delivery. Am J Obstet Gynecol 1997;177:37-41.

104. Hatem M, Dennis KJ. A random plasma glucose method for screening abnormal glucose tolerance in pregnancy. Br J Obstet Gynaecol 1987;94:213-6.

Return to Contents

Notes

Author Affiliations

[a] Brody: Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[b] Harris: Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC.
[c] Lohr: RTI International, Research Triangle Park, North Carolina and UNC School of Public Health, Chapel Hill, NC.

Copyright and Source Information

This document is in the public domain within the United States. For information on reprinting, contact Randie Siegel, Director, Division of Printing and Electronic Publishing, Agency for Healthcare Research and Quality, Suite 501, 2101 East Jefferson Street, Rockville, MD 20852.

Requests for linking or to incorporate content in electronic resources should be sent to: info@ahrq.gov

Source: Brody SC, Harris RH, Lohr K. Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003; 101:380-92.

Return to Contents

Current as of February 2003

Internet Citation:

Brody SC, Harris RH, Lohr K. Screening for Gestational Diabetes: A Summary of the Evidence for the U.S. Preventive Services Task Force. February 2003. Originally in Obstet Gynecol 2003;101:393-95. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/gdm/gdmsum.htm